Evidence map›Paper›PMID 40688659›Full record

ReviewMaterials today. Bio2025

Unlocking the potential of microalgae-derived therapeutic carriers: Characteristics, types, and nanomedical applications.

Peiyi Wang, Changhong Liu, Lei Zheng

Abstract readReview
In one paragraph

Review in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Bioactive Compounds of Ginger (Antibiotics (Basel, Switzerland) · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Peiyi WangEngineering Research Center of Bio-Process, Ministry of Education, School of Food and Biological Engineering, Hefei University of Technology, Hefei, Anhui, 230009, People's Republic of China.
Changhong LiuEngineering Research Center of Bio-Process, Ministry of Education, School of Food and Biological Engineering, Hefei University of Technology, Hefei, Anhui, 230009, People's Republic of China.
Lei ZhengEngineering Research Center of Bio-Process, Ministry of Education, School of Food and Biological Engineering, Hefei University of Technology, Hefei, Anhui, 230009, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Traditional drug delivery systems are constrained by limitations such as low drug-loading efficiency, immunogenicity, and functional simplicity, rendering them inadequate to address the demands of complex pathological scenarios. Microalgae have emerged as a promising alternative system, possessing not only health benefits derived from their bioactive compounds but also inherent properties that naturally align with delivery system requirements. These advantageous characteristics include exceptional biocompatibility, easily modifiable surface properties, and photosynthetic oxygen-generating capacity. Therefore, using microalgae to develop functional natural delivery systems that combine the delivery of therapeutic substances with the regulation of body health is promising. This review provides a detailed exposition of microalgae-based delivery strategies, including the characteristics, advantages, and types of both microalgae and their derived delivery systems. Furthermore, it pays particular attention to their delivery applications in various biomedical fields, as well as the clinical progress, research gaps, and future trends. Overall, microalgae have great potential for the development of natural delivery systems that promote organismal health and enhance biological functionality. In the future, the integration of emerging biosensing and nanotechnologies with microalgae platforms holds great promise for advancing next-generation therapeutic delivery systems with intelligent responsiveness, precise targeting, and personalized treatment capabilities.

Indexed as

Biomedical applicationsDelivery systemHydrogelsMicrorobotsNanotechnology

Identifiers

PMID40688659
PMCPMC12273485

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.